Here’s an article released on 9/22 about a new drug from Swiss drugmaker Novartis that is said to reduce relapses in patients with Multiple Sclerosis. Read more at http://www.kjrh.com/dpp/news/health/novartis-gains-fda-approval-for-new-ms-drug-wews1285193225667
